https://www.auntminnie.com/editors-note/article/15826942/week-in-review-conference-extravaganza-snmmis-image-of-the-year-jeremie-calais-on-theranosticsAuntMinnieen2026-06-06T06:00:00.000ZWeek in Review: Conference extravaganza | SNMMI's Image of the Year | Jeremie Calais on theranosticshttps://www.auntminnie.com/clinical-news/digital-x-ray/article/15826974/most-dcis-sizes-are-either-over-or-underestimated-on-xrayAuntMinnieen2026-06-05T18:56:50.000ZMost DCIS sizes are either over- or underestimated on x-rayhttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/mammography-tech-woman-social.Za6siDVFUM.jpg?auto=format%252Ccompress&q=70https://www.auntminnie.com/clinical-news/molecular-imaging/nuclear-medicine/article/15826970/what-side-effects-do-patients-report-24-hours-after-rptAuntMinnieen2026-06-05T18:29:17.000ZWhat side effects do patients report after Pluvicto therapy?https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/pluvicto-symptoms.TUoWrWNeRH.jpg?auto=format%252Ccompress&q=70Post-Pluvicto SPECT/CT with axial fused images of sacrum and sagittal maximum intensity projection of one of the patients who complained of increasing pain in the sacral region (arrows) post therapy.https://www.auntminnie.com/clinical-news/molecular-imaging/article/15826955/brain-spect-offers-insight-into-suicide-riskAuntMinnieen2026-06-05T16:57:21.000ZBrain SPECT offers insight into suicide riskhttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/suicide.uklOv8tODA.png?auto=format%252Ccompress&q=70https://www.auntminnie.com/clinical-news/molecular-imaging/nuclear-medicine/article/15826840/snmmi-showcast-roundupAuntMinnieen2026-06-05T07:00:00.000ZSNMMI ShowCast Rounduphttps://www.auntminnie.com/clinical-news/molecular-imaging/article/15826877/pet-reveals-brain-receptor-deficits-in-schizophreniaAuntMinnieen2026-06-04T19:34:55.000ZPET reveals brain receptor deficits in schizophreniahttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/aibrain.U0FObJkGzF.jpg?auto=format%252Ccompress&q=70https://www.auntminnie.com/clinical-news/mri/article/15826861/mri-finds-perfusion-defects-across-a-range-of-lung-impairmentsAuntMinnieen2026-06-04T18:53:45.000ZMRI finds perfusion defects across a range of lung impairmentshttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/image.FN8LUuELkS.png?auto=format%252Ccompress&q=70Caption: Representative images show emphysema and functional lung maps derived by CT and PREFUL-MRI: (A–C) CT-derived emphysema images, (D–F) perfusion maps, (G–I) regional ventilation maps, (J–L) flow-volume loop correlation metric maps, (M–O) ventilation/perfusion combined parameter maps. (A, D, G, J, M) Images in a 63-year-old male with normal spirometry: FEV1%pred = 89.0%, FEV1/FVC = 0.73; emphysema percentage = 0.2%, QDP = 7%, VDPRVent = 2%, VDPFVL-CM = 1%. (B, E, H, K, N) Images in a 65-year-old female with PRISm + RP: FEV1%pred = 71.2%, FVC %pred = 76.8%, FEV1/FVC = 0.76; emphysema percentage = 4.7%, QDP = 10%, VD-PRVent = 18%, VDPFVL-CM = 6%. (C, F, I, L, O) Images in a 57-year-old male with AO: FEV1%pred = 56.8%, FEV1/FVC = 0.52; emphysema = 11.1%, QDP = 31%, VDPRVent = 33%, VDPFVL-CM = 41%. AO = airflow obstruction, FEV1 = forced expiratory volume in 1 second, FVC = forced vital capacity, FVL-CM = flow-volume loop correlation metric, %pred = percent predicted, PREFUL = phase-resolved function lung, PRISm = preserved ratio impaired spirometry, QDP = perfusion defect percentage, RVent = regional ventilation, VDP = ventilation defect percentage.https://www.auntminnie.com/clinical-news/ct/article/15826832/ai-detects-lung-cancer-nodules-well-but-shows-low-specificityAuntMinnieen2026-06-04T18:05:43.000ZAI detects lung cancer nodules well but shows low specificityhttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/am2020-06-26-16-29-2945-cancer-lung-400.0A9jJPFaPl.avif?auto=format%252Ccompress&q=70https://www.auntminnie.com/clinical-news/molecular-imaging/article/15826725/aidriven-cardiac-pet-attenuation-correction-shows-promiseAuntMinnieen2026-06-03T18:43:31.000ZAI-driven cardiac PET attenuation correction shows promisehttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/pet-ac.KIgVvG2SOb.png?auto=format%252Ccompress&q=70Cardiac stress test imaging comparison showing DeepAC and CT-based attenuation correction scans for two patients with quantitative perfusion data.https://www.auntminnie.com/clinical-news/interventional/article/15826702/imageguided-focal-laser-ablation-effective-may-treat-prostate-cancerAuntMinnieen2026-06-03T18:23:33.000ZImage-guided focal laser ablation effective for prostate cancerhttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/screenshot-2026-06-03-130312.NLh1Ui0RHp.png?auto=format%252Ccompress&q=70Preablation, postablation, and recurrence multiparametric MRI scans depict a 63-year-old man treated with transperineal focal laser ablation (TPLA) for localized prostate cancer. Clinical parameters included an initial prostate-specific antigen (PSA) level of 7.2 ng/mL, a Prostate Imaging Reporting and Data System (PI-RADS) grade 4 lesion (red circles) in the right apical peripheral zone, and a maximum tumor length of 5 mm. MRI-guided targeted biopsy confirmed a Gleason score 3+4 prostate cancer tumor. (A) Pre-ablation axial T2-weighted MRI scan and apparent diffusion coefficient (ADC) image shows the apical PI-RADS 4 lesion (circles). (B) Six-month post-ablation axial T2-weighted MRI scan and ADC image show cystic necrosis (arrows). There was no evidence of recurrence; the PSA level was 1.5 ng/mL. (C) One-year after ablation, the patient’s PSA level had increased to 4.3 ng/mL. Axial T2-weighted MRI scan and the ADC image shows a recurrent lesion (blue circles) in the right apical peripheral zone adjacent to the ablation scar. Targeted biopsy confirmed Gleason score 3+4 prostate cancer, which was classified as in-field recurrence of clinically significant prostate cancer and subsequently re-treated with TPLA. In summary, serial multiplanar MRI demonstrates treatment response after TPLA with post-ablation necrosis, followed by MRI-detected IFR confirmed with biopsy at 12-month follow-up. Multiparametric MRI was performed with a 3.0-T MRI scanner (Skyra; Siemens Healthineers) using T2-weighted, diffusion-weighted, and ADC sequences, with gadobenate dimeglumine contrast material administration (Bracco Diagnostics).https://www.auntminnie.com/clinical-news/ct/article/15826615/asco-with-boost-from-ai-interventions-boost-lung-cancer-screeningAuntMinnieen2026-06-03T13:12:27.000ZASCO: With help from AI, interventions boost lung cancer screeninghttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/asco-thumb.2UxOsmneCa.jpg?auto=format%252Ccompress&q=70https://www.auntminnie.com/resources/conference/snmmi/2026/article/15826148/integrated-pet-platform-guides-realtime-bone-cancer-margin-assessmentAuntMinnieen2026-06-02T19:15:00.000ZSNMMI: New PET platform guides real-time bone cancer margin assessmenthttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/05/mei.XUQJWkpAJI.jpg?auto=format%252Ccompress&q=70(A-C) Representative whole-body maximum-intensity projection images and regional fused PET/CT images from three histologically confirmed osteosarcoma patients who underwent paired [68Ga]Ga-B7-H3-BCH PET/CT and 18F-FDGE PET/CT within seven days. (D) Multimodal imaging evaluation of Patient Three, including x-ray, MRI (T2-weighted imaging, T2WI), CT, and B7-H3 PET/CT.https://www.auntminnie.com/home/article/15826529/pet-reveals-new-brain-activity-in-multiple-sclerosisAuntMinnieen2026-06-02T19:15:00.000ZSNMMI: PET reveals new brain activity in multiple sclerosishttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/ms-pet.4pNWEjsSUe.jpg?auto=format%252Ccompress&q=70Representative SV2A PET images comparing synaptic density in healthy and disease states. The left panel shows F-18 SynVesT-1 PET distribution volume (VT) maps of the brain and spinal cord in a naïve control mouse and a mouse with experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis. The right panel shows Cu-11 UCB-J PET images of the brain of a 46-year-old male healthy control (left) and 43-year-old female MS patient (right).https://www.auntminnie.com/clinical-news/womens-imaging/article/15826588/ai-approach-could-improve-dbt-efficiencyAuntMinnieen2026-06-02T17:13:07.000ZAI approach could improve DBT efficiencyhttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/2026-06-02-radiology-dbt-slab-ai.AIM4UpUkpd.webp?auto=format%252Ccompress&q=70Slab reconstruction provides visualization of subtle architectural distortion similar to that of standard 1-mm slices in a false-positive screening exam. Images include breast exams from a 45-year-old woman who underwent screening mammography. Craniocaudal tomosynthesis images with <strong>(A)</strong> 1-mm slices and <strong>(B)</strong> 6-mm slab reconstructions show an area of architectural distortion in the subareolar region of the left breast (arrow). <strong>(C)</strong> Targeted ultrasound imaging shows a corresponding irregular hypoechoic mass (arrow), which was subsequently biopsied. Pathologic examination revealed a sclerosing papillary lesion.https://www.auntminnie.com/resources/conference/snmmi/2026/article/15826541/snmmi-biomarkers-predict-i131-response-in-obese-thyroid-cancer-patientsAuntMinnieen2026-06-02T14:07:23.000ZSNMMI: Biomarkers predict I-131 response in obese thyroid cancer patientshttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/snmmi-thumb.1QINdbnH1y.jpg?auto=format%252Ccompress&q=70https://www.auntminnie.com/resources/conference/snmmi/2026/article/15826189/snmmi-theranostic-approach-may-treat-psmanegative-prostate-cancerAuntMinnieen2026-06-02T14:00:00.000ZSNMMI: Theranostic approach may treat PSMA-negative prostate cancerhttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/05/screenshot-2026-05-27-205827.278Ys6PYU3.png?auto=format%252Ccompress&q=70RET-targeted PET tracer highlights neuroendocrine prostate cancer tumors. Representative PET imaging shows strong tumor uptake of the RET-binding peptide tracer [⁶⁸Ga]Ga-DOTA-RET-L7 in a neuroendocrine prostate cancer (NEPC) model, supporting highly specific, high-contrast detection.https://www.auntminnie.com/clinical-news/womens-imaging/breast/article/15826506/asco-use-of-glp1-drugs-linked-to-lower-breast-cancer-casesAuntMinnieen2026-06-02T12:00:00.000ZASCO: Use of GLP-1 drugs linked to lower breast cancer caseshttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/asco-thumb.sCPpzbEikK.jpg?auto=format%252Ccompress&q=70https://www.auntminnie.com/resources/conference/snmmi/2026/article/15826308/snmmi-nextgen-caixtargeted-pet-tracer-detects-clear-cell-renal-cell-carcinomaAuntMinnieen2026-06-01T21:00:00.000ZSNMMI: CAIX-targeted PET tracer detects clear cell renal cell carcinomahttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/05/261784-snmmi2026-jiang-caix-probe.tz1Baak0m6.jpg?auto=format%252Ccompress&q=70A 68Ga-RCC78 PET scan (C) of a patient four years post-radical right nephrectomy. During follow-up, new nodules were detected in the left adrenal gland and kidney. CAIX-targeted scan clearly visualized metastatic lesions in the mediastinum, pancreas, adrenal gland, and kidney (SUVmax > 30), demonstrating the tracer's ability to maintain high tumor uptake despite significantly reduced abdominal background.https://www.auntminnie.com/resources/conference/snmmi/2026/article/15826504/snmmi-lowcost-absorbents-clear-over-90-of-lu177-from-wastewaterAuntMinnieen2026-06-01T20:17:07.000ZSNMMI: Low-cost absorbents clear over 90% of Lu-177 from wastewaterhttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/snmmi-thumb.pkta6q7k3p.jpg?auto=format%252Ccompress&q=70https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/wastewater-2.qmhkL3Rn9q.jpg?auto=format%252Ccompress&q=70Experimental results comparing removal efficiency of three filtration materials: Metal Grid A, Promembranes, and Activated Carbon, with CT and SPECT/CT imaging analysis.https://www.auntminnie.com/resources/conference/snmmi/2026/article/15826256/snmmi-novel-radiotracer-effectively-images-overactive-adrenal-glandsAuntMinnieen2026-06-01T18:15:00.000ZSNMMI: Novel radiotracer effectively images overactive adrenal glandshttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/05/snmmi2026-imaging-adrenal-glands-261581-0105081430.r2zQ3OqCoF.jpg?auto=format%252Ccompress&q=70Static PET-CT image of patient with hypercortisolism taken at 60 minutes post-injection.